Subscribe to RSS - OmniPod


Insulet extends financial assistance to ‘Podders’


ACTON, Mass. – Insulet, maker of the OmniPod system, has expanded its U.S. financial assistance program for current customers who have been negatively impacted by COVID-19.

Insulet reports year-over-year growth


ACTON, Mass. – Insulet Corp. reported revenue of $738.2 million for 2019, a 31% increase compared to 2018.

Insulet reports positive net income for first time


ACTON, Mass. – Insulet Corp. has reported net income of $9.9 million for the fourth quarter of 2018 compared to a net loss of $6.9 million for the same period in 2017.

Insulet reduces net loss


BILLERICA, Mass. – Insulet Corp., maker of the Omnipod Insulin Management System, reported revenues of $124.3 million for the second quarter, a 13% increase compared to the same period last year.

Insulet: ‘We are well on our way’


BILLERICA, Mass. – Insulet Corp. reported revenue of $130.5 million for the fourth quarter of 2017, an increase of 26% compared to the same period in 2016. U.S. revenue from the Omnipod was $76.5 million, an increase of 21%. Full-year revenue was $463.8 million and U.S.

Insulet sees revenues increase across the board


BILLERICA, Mass. – Insulet Corp. reported revenues of $121.8 million for the third quarter of 2017, representing year-over-year growth of 28%. Net loss was 2.2 million. For the Omnipod, revenues in the U.S.

Diabetes in the news, in my life

Thursday, February 2, 2017

CGMs are all around me. Ads for the Dexcom G5, in particular, keep popping up on websites. I am guessing this is because I Googled it while writing a story about Medicare’s recent decision to start paying for certain CGMs (the Dexcom currently being the only one that meets the criteria at this time).

Earnings: Insulet in 'full swing' for 2016


BILLERICA, Mass. – Insulet Corp. execs stand poised to take advantage of the “tremendous market opportunity” for their wireless OmniPod system and other initiatives, they said in a recent earnings call.

Insulet reorganizes executive team


BILLERICA, Mass. – Patrick Ryan, former COO of Insulet, has resigned to “pursue other interests,” the company announced June 30.

Insulet posts third quarter results


BEDFORD, Mass. – Insulet’s revenues reached $61.1 million in the third quarter compared to $54.8 million during the same period last year, a 12% increase, the company announced Nov. 7.